1. Luo, Hao-Lun, Liu, Hui-Ying, Chang, Yin-Lun, Huang, Chun-Chieh, Peng, Jei-Ming. 2021. Hypomethylated RRBP1 Potentiates Tumor Malignancy and Chemoresistance in Upper Tract Urothelial Carcinoma. In International journal of molecular sciences, 22, . doi:10.3390/ijms22168761. https://pubmed.ncbi.nlm.nih.gov/34445467/
2. Lee, Jen-Chieh, Li, Chien-Feng, Huang, Hsuan-Ying, Hornick, Jason L, Fletcher, Jonathan A. 2016. ALK oncoproteins in atypical inflammatory myofibroblastic tumours: novel RRBP1-ALK fusions in epithelioid inflammatory myofibroblastic sarcoma. In The Journal of pathology, 241, 316-323. doi:10.1002/path.4836. https://pubmed.ncbi.nlm.nih.gov/27874193/
3. Sierksma, Annerieke, Lu, Ashley, Mancuso, Renzo, De Strooper, Bart, Fiers, Mark. 2020. Novel Alzheimer risk genes determine the microglia response to amyloid-β but not to TAU pathology. In EMBO molecular medicine, 12, e10606. doi:10.15252/emmm.201910606. https://pubmed.ncbi.nlm.nih.gov/31951107/
4. Shriwas, Omprakash, Arya, Rakesh, Mohanty, Sibasish, Nanda, Ranjan K, Dash, Rupesh. 2021. RRBP1 rewires cisplatin resistance in oral squamous cell carcinoma by regulating Hippo pathway. In British journal of cancer, 124, 2004-2016. doi:10.1038/s41416-021-01336-7. https://pubmed.ncbi.nlm.nih.gov/33762722/
5. Ma, Jing, Ren, Sujing, Ding, Jing, Ma, Rong, Meng, Fanling. 2019. Expression of RRBP1 in epithelial ovarian cancer and its clinical significance. In Bioscience reports, 39, . doi:10.1042/BSR20190656. https://pubmed.ncbi.nlm.nih.gov/31285390/
6. Tang, Lifeng, Zhong, Xuemei, Gong, Hui, Yilamujiang, Subinuer, Li, Li. 2022. Analysis of the association of ANO3/MUC15, COL4A4, RRBP1, and KLK1 polymorphisms with COPD susceptibility in the Kashi population. In BMC pulmonary medicine, 22, 178. doi:10.1186/s12890-022-01975-3. https://pubmed.ncbi.nlm.nih.gov/35513865/
智鼠故事 
